Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice

被引:190
作者
Chao, Che-yi [2 ]
Mong, Mei-chin [2 ]
Chan, Kung-chi [3 ]
Yin, Mei-chin [1 ]
机构
[1] China Med Univ, Dept Nutr, Taichung, Taiwan
[2] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan
[3] Providence Univ, Dept Food & Nutr, Taichung Cty, Taiwan
关键词
Aldose reductase; Diabetes; Glycation; Monocyte chemoattractant protein-1; Tumor necrosis factor-alpha; ALDOSE REDUCTASE; END-PRODUCTS; PATHOGENESIS; ANTIOXIDANT; EXPRESSION; GENES;
D O I
10.1002/mnfr.200900087
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Protective effects of caffeic acid (CA) and ellagic acid (EA) in kidney of diabetic mice were examined. CA or EA at 2.5 and 5% was mixed in diet and supplied to diabetic mice for 12 wk. Results showed that the intake of CA or EA increased renal content of these compounds, alleviated body weight loss, decreased urine output, increased plasma insulin and decreased blood glucose levels at weeks 6 and 12 (p < 0.05). The intake of these compounds dose dependently reduced plasma blood urea nitrogen and elevated creatinine clearance (p < 0.05). CA or EA at 5% significantly decreased the levels of plasma HbA1c, urinary glycated albumin, renal carboxymethyllysine, pentosidine, sorbitol and fructose (p < 0.05), and significantly diminished renal activity of aldose reductase and sorbitol dehydrogenase, as well as suppressed renal aldose reductase mRNA expression (p < 0.05). CA or EA dose dependently lowered renal levels of IL-6, IL-1 beta, tumor necrosis factor (TNE)-alpha and monocyte chemoattractant protein 1 (MCP-1) (p < 0.05). Furthermore, CA or EA dose dependently down-regulated tumor necrosis factor-alpha and monocyte chemoattractant protein-1 mRNA expression in kidney (p < 0.05). Based on the observed anti-glycative and anti-inflammatory effects, the supplement of CA or EA might be helpful for the prevention or attenuation of diabetic kidney diseases.
引用
收藏
页码:388 / 395
页数:8
相关论文
共 31 条
[1]   Plasma interleukin-6 is associated with coagulation in poorly controlled patients with Type 2 diabetes [J].
Aso, Y ;
Okumura, K ;
Yoshida, N ;
Tayama, K ;
Kanda, T ;
Kobayashi, I ;
Takemura, Y ;
Inukai, T .
DIABETIC MEDICINE, 2003, 20 (11) :930-934
[2]  
Bergmeyer H. U., 1974, Methods of Enzymatic Analysis, V2, P569
[3]   Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice [J].
Cheung, AKH ;
Fung, MKL ;
Lo, ACY ;
Lam, TTL ;
So, KF ;
Chung, SSM ;
Chung, SK .
DIABETES, 2005, 54 (11) :3119-3125
[4]   Interaction between the polyol pathway and non-enzymatic glycation on mesangial cell gene expression [J].
Dan, QH ;
Wong, RLC ;
Yin, SN ;
Chung, SK ;
Chung, SSM ;
Lam, KSL .
NEPHRON EXPERIMENTAL NEPHROLOGY, 2004, 98 (03) :E89-E99
[5]   The pathogenesis of diabetic nephropathy [J].
Dronavalli, Suma ;
Duka, Irena ;
Bakris, George L. .
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2008, 4 (08) :444-452
[6]  
DUNLOP M, 2000, KIDNEY INT S, V58, P3
[7]   Cytokine secretion is impaired in women with diabetes mellitus [J].
Geerlings, SE ;
Brouwer, EC ;
van Kessel, KCPM ;
Gaastra, W ;
Stolk, RP ;
Hoepelman, AIM .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2000, 30 (11) :995-1001
[8]   DETERMINATION OF MONOSACCHARIDES AS ALDONONITRILE, O-METHYLOXIME, ALDITOL, AND CYCLITOL ACETATE DERIVATIVES BY GAS-CHROMATOGRAPHY [J].
GUERRANT, GO ;
MOSS, CW .
ANALYTICAL CHEMISTRY, 1984, 56 (04) :633-638
[9]   Renal fate of circulating advanced glycated end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells [J].
Gugliucci, A ;
Bendayan, M .
DIABETOLOGIA, 1996, 39 (02) :149-160
[10]   A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice [J].
Inagi, R ;
Yamamoto, Y ;
Nangaku, M ;
Usuda, N ;
Okamato, H ;
Kurokawa, K ;
de Strihou, CV ;
Yamamoto, H ;
Miyata, T .
DIABETES, 2006, 55 (02) :356-366